We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Circuit Reaffirms Invalidity of Pfizer's Norvasc Patent

Law360 (June 5, 2007, 12:00 AM EDT) -- A circuit court on Tuesday reaffirmed that a Pfizer Inc. patent for popular hypertension drug Norvasc is invalid by overturning a patent infringement ruling against Mylan Laboratories Inc.

The U.S. Court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.